Ecg Medica S.L.

At Ecg Medica S.L. in Valencia, clinical research in cardiovascular diseases focuses on people with hypertension, established cardiovascular disease, and high cardiovascular risk. These trials are designed to assess whether new treatment approaches can better reduce serious heart and vascular events and improve long-term protection for patients.

• Evaluating a new therapy for blood pressure control and cardiovascular risk reduction
• Studying prevention of heart attack, stroke, and heart failure-related events
• Comparing treatment effectiveness in patients with existing heart and vessel disease

This research reflects a strong interest in improving outcomes for patients whose blood pressure remains difficult to manage, especially those already facing elevated cardiovascular danger.

The site is also involved in studies within respiratory tract diseases, with a focus on bronchiectasis. These trials aim to understand whether new treatments can improve disease control, support symptom relief, and offer better options for people living with this chronic lung condition.

• Testing a potential new treatment for bronchiectasis
• Assessing safety and overall treatment benefit in adults with chronic airway disease
• Exploring ways to improve day-to-day respiratory health

This area of research highlights the site’s interest in advancing care for patients with persistent breathing problems and ongoing airway inflammation.

Clinical trials in nutritional and metabolic diseases at Ecg Medica S.L. are centered on obesity and related weight-management concerns, including people with type 2 diabetes. The goal is to evaluate whether investigational treatments can support meaningful weight loss and help improve broader metabolic health.

• Studying a new option for weight reduction in people with overweight or obesity
• Examining whether treatment can support metabolic improvement alongside weight control
• Including patients with obesity and type 2 diabetes to better understand treatment value in complex metabolic disease

This research area is especially relevant for conditions where excess weight contributes to long-term health risks and makes treatment more challenging.

The site’s work in therapeutics includes studies that look at how treatment strategies can be optimized for chronic conditions such as well-controlled recurrent pericarditis. These trials are intended to evaluate transition approaches to a new maintenance therapy and to better understand how long-term disease control can be sustained.

• Assessing treatment transition strategies for recurrent pericarditis
• Evaluating long-term effectiveness of a therapy aimed at maintaining disease control
• Supporting improved management for patients with recurring inflammatory heart conditions

This therapeutic research reflects a broader effort to refine care for patients who need stable, lasting control of chronic inflammatory disease.